| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | |
|---|---|---|
| Revenue | ||
| Cost of revenue | ||
| Operating income | ||
| Operating margin | ||
| Net income | ||
| Net profit margin | ||
| Cash on hand | ||
| Change in cash | ||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 30.37 mm | 30.37 mm | 30.37 mm | 30.37 mm | 30.37 mm | |
| Cash burn (monthly) | 12.02 mm | 6.45 mm | 7.46 mm | 5.69 mm | 2.49 mm | |
| Cash used (since last report) | 60.89 mm | 32.69 mm | 37.79 mm | 28.82 mm | 12.60 mm | |
| Cash remaining | -30.52 mm | -2.32 mm | -7.42 mm | 1.55 mm | 17.77 mm | |
| Runway (months of cash) | -2.5 | -0.4 | -1.0 | 0.3 | 7.1 | |
| 13F holders | Current |
|---|---|
| Total holders | 66 |
| Opened positions | 23 |
| Closed positions | 11 |
| Increased positions | 21 |
| Reduced positions | 10 |
| 13F shares | Current |
|---|---|
| Total value | 22.58 bn |
| Total shares | 15.47 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Bayer Healthcare | 4.05 mm | $8.51 mm |
| Novo Holdings A/S | 1.80 mm | $3.91 bn |
| Ra Capital Management | 1.31 mm | $2.83 bn |
| Farallon Capital Management | 1.06 mm | $2.29 bn |
| Partner Fund Management | 1.03 mm | $2.24 bn |
| Citadel Advisors | 804.46 k | $1.75 bn |
| Hillhouse Capital Advisors | 777.77 k | $1.69 bn |
| Sozo Ventures III | 710.82 k | $7.33 mm |
| BlackRock | 435.66 k | $945.39 mm |
| Millennium Management | 417.88 k | $906.80 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Feb 25 | Eric Bjerkholt | Stock Option Common Stock | Grant | Acquire A | No | No | 2.51 | 42,000 | 105.42 k | 42,000 |
| 5 Dec 24 | Pamela Wapnick | Common Stock | Sell | Dispose S | No | No | 1.86 | 1,559 | 2.90 k | 61,492 |
| 5 Sep 24 | Pamela Wapnick | Common Stock | Sell | Dispose S | No | No | 2.88 | 6,265 | 18.04 k | 63,051 |
| 1 Apr 24 | Brian C. Thomas | Common Stock | Grant | Acquire A | No | No | 0 | 118,992 | 0.00 | 2,496,276 |
| 1 Apr 24 | Brian C. Thomas | Stock Option Common Stock | Grant | Acquire A | No | No | 10.82 | 500,323 | 5.41 mm | 500,323 |
